We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+1.61%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$71.7B
AUM Growth
+$2.34B
Cap. Flow
+$1.49B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.97%
Holding
3,809
New
183
Increased
1,708
Reduced
1,572
Closed
206

Sector Composition

Rank Sector Weight
1 Technology 10.59%
2 Financials 9.51%
3 Healthcare 8.04%
4 Industrials 6.62%
5 Communication Services 5.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPL
3501
DELISTED
Great Panther Mining Limited
GPL
$22K ﹤0.01%
3,050
+2,000
+190% +$16K
PDS
3502
Precision Drilling
PDS
$974M
$21K ﹤0.01%
907
MCHP icon
3503
CALL
Microchip Technology
MCHP
$46B
$19K ﹤0.01%
44,400
-230,600
-84% -$10.5M
SNGX icon
3504
Soligenix
SNGX
$5.81M
$19K ﹤0.01%
82
+21
+34% +$5.19K
CMP icon
3505
CALL
Compass Minerals
CMP
$1.15B
$18K ﹤0.01%
+19,800
New +$1.06M
PFE icon
3506
CALL
Pfizer
PFE
$153B
$18K ﹤0.01%
207,954
-139,761
-40% -$5.08M
IWM icon
3507
PUT
iShares Russell 2000 ETF
IWM
$81.9B
$17K ﹤0.01%
25,300
-14,400
-36% -$2.2M
TGB
3508
Trekor Metals
TGB
$3.05B
$17K ﹤0.01%
40,700
USB icon
3509
CALL
US Bancorp
USB
$99.6B
$17K ﹤0.01%
27,800
-36,800
-57% -$1.99M
QHC
3510
DELISTED
Quorum Health Corporation
QHC
$17K ﹤0.01%
13,762
EXEL icon
3511
CALL
Exelixis
EXEL
$13.4B
$16K ﹤0.01%
26,900
-60,700
-69% -$1.23M
MTBL
3512
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
$16K ﹤0.01%
65,400
NEOS
3513
DELISTED
Neos Therapeutics, Inc
NEOS
$16K ﹤0.01%
10,500
CBL
3514
DELISTED
CBL& Associates Properties, Inc.
CBL
$16K ﹤0.01%
12,190
+996
+9% +$1.04K
IDXG
3515
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$16K ﹤0.01%
2,000
AVT icon
3516
CALL
Avnet
AVT
$7.92B
$15K ﹤0.01%
11,100
+700
+7% +$30.2K
BX icon
3517
CALL
Blackstone
BX
$110B
$15K ﹤0.01%
25,000
+10,000
+67% +$488K
ECT
3518
DELISTED
ECA Marcellus Trust 1 Interest
ECT
$15K ﹤0.01%
12,300
-3,104
-20% -$4.56K
WPRT
3519
PUT
Westport Fuel Systems
WPRT
$35.7M
$14K ﹤0.01%
+2,000
New +$56.8K
UNP icon
3520
CALL
Union Pacific
UNP
$174B
$13K ﹤0.01%
98,100
+39,100
+66% +$6.57M
LCTX icon
3521
Lineage Cell Therapeutics
LCTX
$278M
$12K ﹤0.01%
12,213
CELGZ
3522
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
$12K ﹤0.01%
+21,500
New +$12K
MTNB icon
3523
Matinas BioPharma
MTNB
$1.81M
$11K ﹤0.01%
340
+90
+36% +$3.25K
SBUX icon
3524
CALL
Starbucks
SBUX
$120B
$11K ﹤0.01%
10,100
FTR
3525
DELISTED
Frontier Communications Corp.
FTR
$11K ﹤0.01%
12,537
-4,075
-25% -$4.58K

Similar funds

Raymond James & Associates's Q3 2019 Portfolio in Review

As of Q3 2019, Raymond James & Associates held 3,809 positions worth $71.7B, up 3.4% from $69.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Raymond James & Associates's Q3 2019 filing shows 183 new, 1,708 increased, 1,572 reduced and 206 closed positions. Its largest new stake was Change Healthcare Inc. Common Stock: 949,970 shares worth $11.5M. The largest sale was Microchip Technology, an estimated $155M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2019 buy was Change Healthcare Inc. Common Stock: 949,970 shares worth $11.5M.
  • Raymond James & Associates added most to Comcast in Q3 2019, an estimated $203M increase.
  • Raymond James & Associates's biggest Q3 2019 reduction was Microchip Technology, cutting an estimated $155M.
  • Raymond James & Associates fully exited Anadarko Petroleum in Q3 2019, selling an estimated $89.3M.
  • Raymond James & Associates's ten largest holdings make up 22% of its $71.7B portfolio in Q3 2019.
  • Raymond James & Associates opened 183 new positions and closed 206 in Q3 2019.
  • Raymond James & Associates's portfolio value rose 3.4% quarter-over-quarter to $71.7B.

Based on Raymond James & Associates's 13F filing for Q3 2019, filed 7 Nov 2019.